These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1848 related articles for article (PubMed ID: 31294387)

  • 1. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
    Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Card TR; Langan SM; Chu TP
    Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
    Burisch J; Jess T; Egeberg A
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient awareness of extraintestinal manifestations of inflammatory bowel disease.
    Huang V; Mishra R; Thanabalan R; Nguyen GC
    J Crohns Colitis; 2013 Sep; 7(8):e318-24. PubMed ID: 23265763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extradigestive manifestations of IBD in pediatrics.
    Aloi M; Cucchiara S
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():23-32. PubMed ID: 19530508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease.
    Annese V
    Saudi J Med Med Sci; 2019; 7(2):66-73. PubMed ID: 31080385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
    Rogler G; Singh A; Kavanaugh A; Rubin DT
    Gastroenterology; 2021 Oct; 161(4):1118-1132. PubMed ID: 34358489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
    Attauabi M; Zhao M; Bendtsen F; Burisch J
    Inflamm Bowel Dis; 2021 May; 27(6):927-939. PubMed ID: 32628745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology and the pathogenesis of inflammatory bowel disease.
    Karlinger K; Györke T; Makö E; Mester A; Tarján Z
    Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study.
    Vernero M; Saibeni S; Scalvini D; Cicalini C; Chiarello L; Nardi S; Ribaldone DG; Bezzio C
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398332
    [No Abstract]   [Full Text] [Related]  

  • 17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease.
    Siemanowski B; Regueiro M
    Curr Treat Options Gastroenterol; 2007 Jun; 10(3):178-84. PubMed ID: 17547856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of extraintestinal manifestations in inflammatory bowel disease.
    Lakatos PL; Lakatos L; Kiss LS; Peyrin-Biroulet L; Schoepfer A; Vavricka S
    Digestion; 2012; 86 Suppl 1():28-35. PubMed ID: 23051724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.
    Attauabi M; Wewer MD; Bendtsen F; Seidelin JB; Burisch J
    Inflamm Bowel Dis; 2022 Nov; 28(11):1756-1765. PubMed ID: 35134921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 93.